| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 06/30/2004 | CN1155601C Dioxacyclopentedien-6-(5aH)-one compound, its preparation process and medicinal composition |
| 06/30/2004 | CN1155377C Anti-first-pass effect compounds |
| 06/29/2004 | US6756383 Such as 3-(2-(methoxycarbonyl)acetylamino)pyridine-4-carboxylic acid for treatment of diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases; enzyme inhibitors |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |
| 06/24/2004 | WO2004052894A1 Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
| 06/24/2004 | WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 06/24/2004 | US20040122239 via dehydrogenation; for production of semiconductor polymers/light emitting diodes |
| 06/24/2004 | US20040122037 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity |
| 06/24/2004 | US20040122035 selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase-5 (PDE5); sexual disorders, cardiovascular disorders; 1-(2H-benzo[d]1,3-dioxolan-5-yl)(1,2,3,4-tetrahydro- beta -carbolin-2-yl)-2-naphthyl ketone for example |
| 06/24/2004 | DE10256264A1 New trisubstituted dihydro-imidazo-pyridazinone or imidazo-pyridinone derivatives, useful as dipeptidylpeptidase-IV inhibitors for e.g. treating diabetes mellitus type I or II, arthritis or obesity |
| 06/24/2004 | CA2506529A1 Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
| 06/23/2004 | EP1430898A1 Receptor antagonist |
| 06/23/2004 | EP1430147A1 Fluorescent quenching detection reagents and methods |
| 06/23/2004 | CN1506366A Preparation of 2,2'-di(3,4-ethylenedioxy-thiophene) |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/22/2004 | US6753430 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 06/22/2004 | US6753333 Arginine salt forms of s-(-)-9- fluoro-6,7-dihydro 8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo(i,j)quinolizine-2 -carboxylic acid, a process for their preparation and pharmaceutical formulations which are |
| 06/17/2004 | WO2004050659A1 Novel compounds as pharmaceutical agents |
| 06/17/2004 | WO2004050658A1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments |
| 06/17/2004 | WO2004050036A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 06/17/2004 | US20040116719 Azadiracthin dissolved in polarity solvent; mixing using aqeous salt solution; recovering |
| 06/17/2004 | US20040116698 6-Substituted pyrido-pyrimidines |
| 06/17/2004 | US20040116461 Immunomodulatory compounds |
| 06/17/2004 | US20040116460 Anticancer agents |
| 06/17/2004 | US20040116426 Small molecules useful in the treatment of inflammatory disease |
| 06/17/2004 | US20040115283 Administering parenterally a therapeutically effective amount of one or more arsenic compounds |
| 06/16/2004 | EP1428827A1 Derivatives of 2,2'-Di (3,4-alkylenedioxythiophen) their preparation and use |
| 06/16/2004 | EP1427710A2 Method for the production of cna |
| 06/16/2004 | EP1427413A2 2-aroylimidazole compounds for treating cancer |
| 06/16/2004 | EP1427407A2 Fatty amine drug conjugates |
| 06/16/2004 | EP1341763B1 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization |
| 06/16/2004 | EP1196418B1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES |
| 06/16/2004 | CN1505509A Method for treating allergies using substituted pyrazoles |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
| 06/10/2004 | WO2004048378A1 Pyrazoloquinolines with immunomodulating activity |
| 06/10/2004 | US20040110826 Alpha 2c-adrenoceptor antagonists comprising 1- (benzylamino)-1,2,4]triazolo[1,5-c]pyrimidine derivatives; Parkinson's disease, dyskinesias, antidepressants; hypotensive, antidiabetic agents; eating,sexual disorders |
| 06/10/2004 | CA2506524A1 Pyrazoloquinolines with immunomodulating activity |
| 06/09/2004 | EP1426377A1 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis of vinblastines |
| 06/09/2004 | EP1425286A1 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of diseases |
| 06/09/2004 | EP1425284A2 Furo- and thienopyrimidine derivatives as angiogenesis inhibitors |
| 06/09/2004 | EP1425283A1 Novel 4-aminofuropyrimidines and the use thereof |
| 06/09/2004 | EP1098897B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/09/2004 | CN1503802A Sulfate of cephem compound |
| 06/09/2004 | CN1503801A Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 06/09/2004 | CN1503800A antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 06/09/2004 | CN1503799A Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene |
| 06/09/2004 | CN1503798A Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- [1,4]-derivatives of oxaheterocycle-fused-[1,4]-benzodioxans |
| 06/09/2004 | CN1503797A Pyridopyrimidine or naphthyridine derivative |
| 06/09/2004 | CN1503793A N-substituted nonabyl-heterocyclic nmda/nrzb antagonists |
| 06/09/2004 | CN1503672A 6-substituted pyrido-pyrimidines |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/08/2004 | US6747032 Pyrimidin-4-one compounds |
| 06/03/2004 | US20040106787 Porphyrin array exhibiting large two photon absorption property and including, as structural unit, bis(imidazolylporphyrin metal complex) linked with acetylenic bond and the derivative thereof, and method of producing the same |
| 06/02/2004 | EP1424691A2 Optical information-recording medium, novel oxonol compound and method of recording information |
| 06/02/2004 | EP1423391A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 06/02/2004 | EP1423119A1 Heterobicycles fkbp-ligands |
| 06/02/2004 | EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1204662B1 Azaindoles having serotonin receptor affinity |
| 06/02/2004 | CN1501932A Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1500786A Novel buprenorphine ester derivatives and process for preparing the same and medical compounds with long-acting analgesic effect |
| 06/02/2004 | CN1152034C Process for extracting active anticancer component from vinca flower |
| 06/01/2004 | US6743919 2-aroylimidazole compounds for treating cancer |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743800 Vitronectin receptor antagonists and inhibitors of cell adhesion; osteoporosis, angiogenesis inhibitors |
| 06/01/2004 | US6743798 Cardiovascular disorders; vasorelaxation, inhibition of platelet aggregation, decrease in blood pressure; stimulation of soluble guanylate cyclase and an intracellular cgmp increase |
| 05/27/2004 | WO2004043912A2 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/27/2004 | WO2004033456A3 1,4-diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors |
| 05/27/2004 | WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 05/27/2004 | WO2002099141A9 Fluorescent quenching detection reagents and methods |
| 05/27/2004 | US20040102450 Substituted oxoazaheterocyclyl compounds |
| 05/27/2004 | CA2505365A1 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/26/2004 | CN1500090A Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 05/21/2004 | WO2004041820A1 Novel xanthine derivatives, the production and the use thereof in the form of drugs |
| 05/21/2004 | WO2004041818A1 Anti-infective agents |
| 05/21/2004 | WO2004041210A2 Antibacterial agents |
| 05/21/2004 | WO2004041162A2 Inhibitors of akt activity |
| 05/21/2004 | WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 05/20/2004 | US20040097725 Charge transport compositions and electronic devices made with such compositions |
| 05/20/2004 | US20040097545 Quinolinone derivatives |
| 05/20/2004 | US20040097526 Using triazolo(4,5-d)pyrimidine derivatives or a pharmaceutically acceptable salt or prodrug, in manufacture of a medicament for therapy or prevention of a disorder in which blocking of purine receptors may be beneficial |
| 05/20/2004 | US20040097498 For prophylaxis and/or therapy of disorders of the urogenital system such as hypetrophy of the prostate, incontinence and in particular erectile dysfunction and female sexual dysfunction, cerebrovascular disorders |
| 05/20/2004 | US20040097492 For inhibiting hepatitis C virus (HCV) polymerase; therapy and prophylaxis of HCV infection |
| 05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/20/2004 | US20040094818 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1250334B1 Medicaments useful for the treatment of proliferative diseases |
| 05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
| 05/19/2004 | DE10251927A1 New 1,7,8-trisubstituted xanthine derivatives, are dipeptidylpeptidase-IV inhibitors useful e.g. for treating diabetes mellitus type I or II, arthritis or obesity |
| 05/19/2004 | CN1149996C Hexahydro-pyrido(4,3-B) indole derivatives as antipsychotic drugs |
| 05/13/2004 | WO2004039816A1 Crystal of inorganic acid salt of cephem compound |
| 05/13/2004 | WO2004039815A2 Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases |
| 05/13/2004 | WO2004039796A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 05/13/2004 | US20040092737 Benzopiperidine derivatives |
| 05/13/2004 | US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/13/2004 | US20040092582 Antiinflammatory agents; respiratory system disorders; antiarthritic agents; autoimmune diseases; antidiabetic agents |
| 05/13/2004 | US20040092520 Purine compounds and uses thereof |
| 05/13/2004 | US20040092453 Synergistic antineoplastic effect; side effect reduction |
| 05/13/2004 | US20040091742 Naphthalocyanine based charge generating materials; photo-receptor, photoconductive, optical recording, solar cell and/or nonlinear optical materials; synthesis |
| 05/13/2004 | DE10332232A1 Heteroaryloxy-substituierte Phenylaminopyrimidine Heteroaryloxyphenoxyalkanecarboxylic substituted Phenylaminopyrimidine |